Description
S-23 20 mg NovoSarm — Manufactured to exacting pharmaceutical standards, designed for targeted physiological enhancement. Manufactured under strict quality standards. This formulation is dosed at 20 mg per unit.
Key Benefits
- High-potency SARM — full agonist AR profile
- Strong mass-building effect at 10–30 mg/day
- Meaningful HPTA suppression — full PCT required
- Oral once-daily dosing
- More androgenic sides than Ostarine — hair/skin effects possible
- Each unit dosed at 20 mg — see Recommended Dosage below for protocol-specific intake
Recommended Dosage
Research dosing: 10–30 mg/day single morning dose. Cycles 8 weeks. Above 30 mg/day HPTA suppression becomes severe.
How It Works
High-potency SARM with full agonist activity at the AR. Stronger than Ligandrol; feels like a low-dose oral AAS. Developed originally as a male contraceptive candidate due to potent spermatogenic suppression.
Pharmacokinetics
Plasma half-life approximately 12 hours. Once or twice daily dosing. Oral bioavailability good.
Potential Side Effects
HPTA suppression severe at 20+ mg/day. Hair-thinning in predisposed users. HDL drops. Aggression and mood volatility. Full PCT (Nolva + Clomid × 4 weeks) mandatory.
Cycle & Stacking Guide
8-week cycles at 10–20 mg/day. Full PCT. Not a beginner SARM. Stacks with Ostarine or cardarine for cutting-recomp if aggressive results are the goal.
Manufacturer Notes
NovoSarm is an independent producer in the research-compound market. Before first use, request the batch-specific Certificate of Analysis and confirm the vial’s tamper-evident seal is intact.
Storage & Handling
Store at recommended temperature (15–25°C; peptides and HGH at 2–8°C after reconstitution). Protect from light and moisture. Keep out of reach of children. For research and educational purposes only.
Reviews
There are no reviews yet.